Treatment of Periprosthetic Infection with Silver-Doped Implants Based on Two-Dimensionally Ordered Linear Chain Carbon

封面


如何引用文章

全文:

详细

Relevance. Formation of pan-resistance microorganisms, microbial biofilms on implants and recurrent infection rate stimulate the search for optimal prosthesis materials for treatment of periprosthetic infection (PJI). Purpose of the study — to compare the efficiency of two stage PJI treatment with simultaneous implantation of a spacer in combination with implants with silver-doped coatings based on two-dimensionally ordered linear chain carbon (TDOLCC+Ag) during the first stage and the conventional revision with a spacer only. Materials and methods. The study included 72 patients with PJI of the knee (n = 42) and hip (n = 30) joints. Control group (conventional revision) consisted of 35 patients and the main group (TDOLCC+Ag coated implant incorporated in a spacer) — 37 patients. Mean age of the patients was 61 years. Temporary components were replaced by the final components during revision at the second stage. Evaluation methods: clinical, X-ray, laboratory, microbiological and follow up history. Results. Inflammation markers and synovial fluid cytosis in the groups at the first revision stage featured equal high base values. During the second stage leucocyte count and cytosis reached normal values, ESR decreased twofold in both groups, CRP decreased five times in the main group. Throat and nasal swabs demonstrated growth of Staphylococcus aureus at 24,3-32,4% in both groups. The leading inducer of PJI was staphylococcal flora with MRSA share of 7,1% and MRSE — from 62,5 to 66,7%. End-points of evaluating treatment outcomes were revision spacer implantation at the second stage of sanation and recurrent PJI. Control group featured implantation of more revision spacers (5) as compared to the main group (1) after the treatment. Two recurrent PJIs were reported for the control group in 11 months while no recurrent infection was reported for the main group. Conclusion. The study demonstrated statistically significant improvement in the outcomes of PJI treatment by spacers with implants coated by TDOLCC+Ag as compared to the conventional treatment option.

作者简介

N. Nikolaev

Federal Center of Traumatology, Orthopedics and Endoprosthesis Replacement;
Ulyanov Chuvash State University

Email: fake@neicon.ru
Nikolai S. Nikolaev — Dr. Sci. (Med.), Professor, Chief Physician;
Head of Department of Traumatology, Orthopedics and Emergency Medicine 俄罗斯联邦

L. Lyubimova

Federal Center of Traumatology, Orthopedics and Endoprosthesis Replacement

Email: fake@neicon.ru
Lyudmila V. Lyubimova — Clinical Pharmacologist 俄罗斯联邦

N. Pchelova

Federal Center of Traumatology, Orthopedics and Endoprosthesis Replacement

Email: fake@neicon.ru
Nadezhda N. Pchelova — Сlinical Laboratory Diagnostics Doctor 俄罗斯联邦

E. Preobrazhenskaya

Federal Center of Traumatology, Orthopedics and Endoprosthesis Replacement

编辑信件的主要联系方式.
Email: fc@orthoscheb.com
Elena V. Preobrazhenskaya — Head of Research Department 俄罗斯联邦

A. Alekseeva

Federal Center of Traumatology, Orthopedics and Endoprosthesis Replacement

Email: fake@neicon.ru
Alena V. Alekseeva — Orthopedic Surgeon 俄罗斯联邦

参考

  1. Goel R., Tarabichi M., Azboy I., Kheir M., Parvizi J. Management of periprosthetic joint infection. Minerva Ortopedica e Traumatologica. 2017;68(4):207-215. doi: 10.23736/S0394-3410.17.03842-5.
  2. Bruellhoff K., Fiedler J., Möller M., Groll J., Brenner R.E. Surface coating strategies to prevent biofilm formation on implant surfaces. Int J Artif Organs. 2010;33(9):646-653. doi: 10.1177/039139881003300910.
  3. Kheir M.M., Parvizi J., Fleischman A.N., Albers A., Duncan C.P., Masri B.A. et al. Complications of Total Hip Arthroplasty. In: Orthopaedic Knowledge Update. Hip and Knee Reconstruction 5. Mont M.A., Tanzer M. (eds). Amer Academy of Orthopaedic; 2017. p. 473-505.
  4. Krebs V.E., Malkani A.L., Ulrich S.D., Backstein D., Abolghasemian M., Springer B.D., Samujh Ch. Complications of Knee Arthroplasty. In: Orthopaedic Knowledge Update. Hip and Knee Reconstruction 5. Mont M.A., Tanzer M. (eds). Amer Academy of Orthopaedic; 2017. p. 233-266.
  5. Андреева Т.М., Огрызко Е.В., Попова М.М., сост. Травматизм, ортопедическая заболеваемость, состояние травматолого-ортопедической помощи населению России в 2017 году: ежегодный статистический сборник. М.; 2018. c. 148-149..
  6. Zimmerli W., Moser C. Pathogenesis and treatment concepts of orthopaedic biofilm infections. FEMS Immunol Med Microbiol. 2012;65(2):158-168. doi: 10.1111/j.1574-695X.2012.00938.x.
  7. Romano C.L., Scarponi S., Gallazzi E., Romano D., Drago L. Antibacterial coating of implants in orthopaedics and trauma: a classification proposal in an evolving panorama. J Orthop Surg Res. 2015;10:157. doi: 10.1186/s13018-015-0294-5.
  8. Parvizi J., Shohat N., Gehrke T. Prevention of periprosthetic joint infection: new guidelines. Bone Joint J. 2017;99-B(4 Supple B):3-10. doi: 10.1302/0301-620X.99B4.BJJ-2016-1212.R1.
  9. Kalmeijer M.D., van Nieuwland-Bollen E., BogaersHofman D., de Baere G.A. Nasal carriage of Staphylococcus aureus is a major risk factor for surgicalsite infections in orthopedic surgery. Infect Control Hosp Epidemiol. 2000;21(5):319-323. doi: 10.1086/501763.
  10. Schweizer M., Perencevich E., McDanel J., Carson J., Formanek M., Hafner J. et al. Effectiveness of a bundled intervention of decolonization and prophylaxis to decrease Gram positive surgical site infections after cardiac or orthopedic surgery: systematic review and metaanalysis. BMJ. 2013;346:f2743. doi: 10.1136/bmj.f2743.
  11. Weiser M.C., Moucha C.S. The Current State of Screening and Decolonization for the Prevention of Staphylococcus aureus Surgical Site Infection After Total Hip and Knee Arthroplasty. J Bone Joint Surg Am. 2015;97(17):1449-1458. doi: 10.2106/JBJS.N.01114.
  12. Sadigursky D., Pires H.S., Rios S.A.C., Filho F.L.B.R., Castro de Queiroz G., Azi M.L. Prophylaxis with nasal decolonization in patients submitted to total knee and hip arthroplasty: systematic review and meta-analysis. Rev Bras Ortop. 2017;52(6): 631-637. doi: 10.1016/j.rboe.2016.10.018.
  13. Голуб А.В. Бактериальные биопленки — новая цель терапии? Клиническая микробиологическая антимикробная химиотерапия. 2012;(1):23-29.
  14. Koseki H., Yonekura A., Shida T., Yoda I., Horiuchi H., Morinaga Y. et al. Early staphylococcal biofilm formation on solid orthopaedic implant materials: in vitro study. PLoS One. 2014;9(10):e107588. doi: 10.1371/journal.pone.0107588.
  15. Shirai T., Shimizu T., Ohtani K., Zen Y., Takaya M., Tsuchiya H. Antibacterial iodine-supported titanium implants. Acta Biomater. 2011;7(4):1928-1933. doi: 10.1016/j.actbio.2010.11.036.
  16. Казбанов В.В., Баталов М.С., Вишневский А.А. Особенности биосовместимости и перспективы применения титановых имплантатов с алмазоподобными покрытиями на основе модифицированного углерода. Проблемы здоровья и экологии. 2015;(2):16-23.
  17. Тапальский Д.В., Николаев Н.С., Овсянкин А.В., Кочаков В.Д., Головина Е.А., Матвеенков М.В. и др. Покрытия на основе двумерно упорядоченного линейно-цепочечного углерода для защиты титановых имплантатов от микробной колонизации. Травматология и ортопедия России. 2019;(2):111-120. doi: 10.21823/2311-2905-2019-25-2-111-120.
  18. Александров А.Ф., Гусева М.Б., Корнеева Ю.В., Новикова Н.Д., Хвостов В.В. Результаты и перспективы применения биосовместимых форм линейно-цепочечного углерода в медицине. Интеграл. 2011;61(5):27-31.
  19. Винклер Т., Трампуш А., Ренц Н., Перка К., Божкова С.А. Классификация и алгоритм диагностики и лечения перипротезной инфекции тазобедренного сустава. Травматология и ортопедия России. 2016;(1):33-45. doi: 10.21823/2311-2905-2016-0-1-33-45.
  20. Николаев Н.С., Борисова Л.В., Пчелова Н.Н., Орлова А.В., Каралин А.Н. Практические рекомендации по диагностике имплант-ассоциированной инфекции при эндопротезировании крупных суставов в современных условиях. Медицинский альманах. 2016;3(43): 40-45. doi: 10.21145/2499-9954-2016-3-40-45.
  21. Trampuz A., Perka C. Borens O. Gelenkprotheseninfektion: Neue Entwicklungen in der Diagnostik und Therapie. Dtsch med Wochenschr. 2013;138(31/32): 1571-1573. (In German). doi: 10.1055/s-0033-1343280.
  22. Trampuz A., Piper K.E., Jacobson M.J., Hanssen A.D., Unni K.K., Osmon D.R. et al. Sonication of Removed Hip and Knee Prostheses for Diagnosis of Infection. N Engl J Med. 2007;357(7):654-663. doi: 10.1056/NEJMoa061588.
  23. Zimmerli W., Trampuz A., Ochsner P.E. ProstheticJoint Infections. N Engl J Med. 2004;351(16):1645-1654. doi: 10.1056/NEJMra040181.
  24. Божкова С.А., Богданова Т.Я., Краснова М.В., Анисимова Л.О., Нетылько Г.И., Рукина А.Н. и др. Экспериментально-клиническое исследование фенотипических особенностей штаммов s.epidermidis и их роль в возникновении и развитии имплант-ассоциированной инфекции после ортопедических операций. Травматология и ортопедия России. 2014;(2):68-77. doi: 10.21823/2311-2905-2014-0-2-68-77.
  25. Botelho A.M., Nunes Zd., Asensi M.D., Gomes M.Z., Fracalanzza S.E., Figueiredo A.M. Characterization of coagulase-negative staphylococci isolated from hospital indoor air and a comparative analysis between airborne and inpatient isolates of Staphylococcus epidermidis. J Med Microbiol. 2012;61(Pt 8):1136-1145. doi: 10.1099/jmm.0.035931-0.
  26. Schäfer P., Fink B., Sandow D., Margull A., Berger I., Frommelt L. Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy. Clin Infect Dis. 2008;47(11):1403-1409. doi: 10.1086/592973.
  27. Schinsky M.F., Della Valle C.J., Sporer S.M., Paprosky W.G. Perioperative testing for joint infection in patients undergoing revision total hip arthroplasty. J Bone Joint Surg Am. 2008;90(9):1869-1875. doi: 10.2106/JBJS.G.01255. Erratum in: Bone Joint Surg Am. 2010;92(3):707.
  28. Борисова Л.В., Дидиченко С.Н., Орлова А.В., Пчелова Н.Н. Оптимальные методы лечения инфекционных осложнений при эндопротезировании крупных суставов в современных условиях. Уральский медицинский журнал. 2015;33(10):151-156.
  29. Parvizi J., Erkocak O.F., Della Valle C.J. Culture-negative periprosthetic joint infection. J Bone Joint Surg Am. 2014;96-A:430-436. doi: 10.2106/JBJS.L.01793.
  30. Bori G., Navarro G., Morata L., Fernández-Valencia J.A., Soriano A., Gallart X. Preliminary results after changing from two-stage to one-stage revision arthroplasty protocol using cementless arthroplasty for chronic infected hip replacements. J Arthroplasty. 2018;33(2):527-532. doi: 10.1016/j.arth.2017.08.033.
  31. Jenny J.Y., Lengert R., Diesinger Y., Gaudias J., Boeri C., Kempf J.F. Routine one-stage exchange for chronic infection after total hip replacement. Int Orthop. 2014;38(12):2477-2481. doi: 10.1007/s00264-014-2466-z.
  32. Kendoff D., Gehrke T. Surgical management of periprosthetic joint infection: one-stage exchange. J Knee Surg. 2014;27(4):273-278. doi: 10.1055/s-0034-1376882.
  33. Parvizi J., Adeli B., Zmistowski B., Restrepo C., Greenwald A.S. Management of periprosthetic joint infection: the current knowledge: AAOS exhibit selection. J Bone Joint Surg Am. 2012;94(14):104. doi: 10.2106/JBJS.K.01417.
  34. Божкова С.А. Современные принципы диагностики и антибактериальной терапии инфекции протезированных суставов (обзор литературы). Травматология и ортопедия России. 2011;(3):126-136. doi: 10.21823/2311-2905-2011-0-3-126-136.
  35. Choi H.R., von Knoch F., Kandil A.O., Zurakowski D., Moore S., Malchau H. Retention treatment after periprosthetic total hip arthroplasty infection. Int Orthop. 2012;36(4):723-729. doi: 10.1007/s00264-011-1324-5.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © ,


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 82474 от 10.12.2021.


##common.cookie##